Judith Feucht - Concepedia

Author

Judith Feucht

University Children's Hospital Tübingen ORCID

Also Known As

Hendrik Wiethoff, J Feucht, J. Feucht, Judith Feucht

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University Children's Hospital Tübingen Memorial Sloan Kettering Cancer Center Ludwig-Maximilians-Universität München Cornell University Howard Hughes Medical Institute

About

Judith Feucht is an author at University Children's Hospital Tübingen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2.2K
2	Cell Biology	6	6	2K
3	Cellular Therapies	3	3	220
4	Health Sciences	2	2	177
5	Blood Transplantation	1	1	15

Judith Feucht

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Senolytic CAR T cells reverse senescence-associated pathologies Corina Amor, Judith Feucht, Josef Leibold, Nature T-regulatory CellImmunologyCellular SenescenceAutoimmunityImmunotherapy	2020	968
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency Judith Feucht, Jie Sun, Justin Eyquem, Nature Medicine Signal TransductionAdaptive Immune SystemT-regulatory CellImmunologyAutoimmunity	2018	512
NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination Marcus Ruscetti, Josef Leibold, Matthew J. Bott, Science	2018	416
HLA-independent T cell receptors for targeting tumors with low antigen density Jorge Mansilla‐Soto, Justin Eyquem, Sascha Haubner, Nature Medicine Cancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityAntigen Processing	2022	172
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts Judith Feucht, Simone Kayser, David Gorodezki, Oncotarget	2016	169
Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia Franziska Blaeschke, Dana Stenger, Theresa Kaeuferle, Cancer Immunology Immunotherapy Cell TherapyMedicineActive Cd4+HematologyImmunology	2018	154
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction Corina Amor, Inés Fernández-Maestre, Saria Chowdhury, Nature Aging Anti-agingAgingT-regulatory CellImmunologyLong-lasting Efficacy	2024	148
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT Judith Feucht, Kathrin Opherk, Peter Lang, Blood	2015	142
TET2 guards against unchecked BATF3-induced CAR T cell expansion Nayan Jain, Zeguo Zhao, Judith Feucht, Nature	2023	136
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab P. Schlegel, Peter Lang, Gerhard Zugmaier, Haematologica	2014	134

Page 1